Souhaitez-vous accéder aux communiqués récents ?

This trial is the first large, placebo-controlled clinical trial of an acid suppression treatment in EoETopline results for the double-blind 12-week treatment portion of the study are expected in Q4...

Dublin, June 23, 2026 (GLOBE NEWSWIRE) -- The "Women's Clinical Trials & CROs Market Report 2026-2036" has been added to ResearchAndMarkets.com's offering.The report's release comes as the...

Initiative creates new resource to support and accelerate early-stage therapeutics companies Parexel forms inaugural partnership with Durham-based Cape Fear BioCapital to connect incubator to a...

NEW YORK, June 22, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today introduced its Academic Site...

The IRIS Phase 2 trial did not meet its primary endpoint in social communication deficits associated with ASD A prespecified analysis in adolescents with moderate to severe baseline irritability...

Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026

Avance Clinical Announces Asia Pacific and Mainland China Expansion Ahead of BIO International Convention 2026

Arletta Pharma Solutions Appoints Steve van Os, MD, as Chief Medical Officer. Experience at Astellas, Organon, Schering-Plough, Antev, Millicent Pharma.

"Visting our CDMO partner provides tremendous benefits being able to visualize future cGMP production of PRP"

New high-value indication for Phase 3-ready asset with data intended to support clinical development and strategic partnering discussionsAdditional billion-dollar target- Cardiac Surgery-Associated...